ULTIMA Journal Research

NFMT and light therapy in facial care alongside botulinum toxin treatments

Originally published:

Botulinum toxin treatments are commonly used to soften expression lines and support a more youthful appearance. Reduced muscle activity can also affect muscle volume. The original professional article explores the potential complementary role of Neuroadaptive Facial Muscle Therapy (NFMT) and red light therapy in supporting facial contours and skin condition.

ULTIMA FACE uses gentle electrical impulses to elicit muscle contractions. The article relates this to support for muscle activity, local circulation and a firmer facial appearance. However, prevention or reversal of botulinum toxin-related muscle atrophy is not an established ULTIMA outcome on the basis of the evidence presented here. Suitability and timing of combined treatment must be determined by the treating physician.

The report also discusses the potential skin effects of 660 nm red light and 940 nm near-infrared light. Its topics include collagen- and elastin-related processes, skin texture and elasticity, tissue repair and inflammatory processes. Evidence for a particular device and protocol must be evaluated separately from the general research background on light therapy.

The article refers to research on electrical stimulation and light-based treatments. The reference originally attributed to Matsumoto et al. (2019) could not be verified as support for the NFMT claim and is therefore not used as evidence. The review by Avci et al. provides general research background on light therapy; it is not, by itself, clinical evidence for combining ULTIMA with botulinum toxin.

The combined approach aims to support skin appearance, facial contours and long-term facial care. The original report mentions favourable user experiences regarding facial symmetry, skin tone and a more youthful appearance. These experiences do not replace controlled clinical data specifically investigating this treatment combination.

A professional consultation can help you explore the options offered by ULTIMA. Always inform your practitioner about previous or planned injectable treatments.

Avci et al. (2013): Low-level laser (light) therapy (LLLT) in skin · MuscleGuard

Editorial note: this historical report includes professional clarifications. Research observations, author opinions and participant experiences do not establish a guaranteed treatment outcome for everyone.